We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HHH icon
226
Howard Hughes
HHH
$3.98B
$453K 0.04%
3,839
– –
AMP icon
227
Ameriprise Financial
AMP
$49.9B
$447K 0.04%
3,081
+26
+0.9% +$3.76K
Y
228
DELISTED
Alleghany Corp
Y
$446K 0.04%
655
+35
+6% +$23.2K
EOG icon
229
EOG Resources
EOG
$75.1B
$433K 0.04%
4,653
-401
-8% -$37.3K
GLW icon
230
Corning
GLW
$144B
$428K 0.04%
12,867
+324
+3% +$10.4K
FTV icon
231
Fortive
FTV
$18.6B
$427K 0.04%
8,311
-54
-0.6% -$2.8K
DEM icon
232
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$425K 0.04%
9,514
-1,804
-16% -$79K
MS icon
233
Morgan Stanley
MS
$342B
$421K 0.04%
9,614
-77
-0.8% -$3.43K
SNY icon
234
Sanofi
SNY
$105B
$417K 0.03%
9,638
-875
-8% -$37.2K
PSX icon
235
Phillips 66
PSX
$90B
$416K 0.03%
4,451
+497
+13% +$44.6K
BIV icon
236
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
$409K 0.03%
4,728
+1,695
+56% +$143K
IWR icon
237
iShares Russell Mid-Cap ETF
IWR
$57.9B
$405K 0.03%
7,254
+1,176
+19% +$64.5K
EPD icon
238
Enterprise Products Partners
EPD
$81.9B
$402K 0.03%
13,918
– –
LH icon
239
Labcorp
LH
$26.2B
$394K 0.03%
2,653
+466
+21% +$65K
XYL icon
240
Xylem
XYL
$28.5B
$390K 0.03%
4,663
-1,863
-29% -$148K
BRKL
241
DELISTED
Brookline Bancorp
BRKL
$389K 0.03%
25,335
-300
-1% -$4.48K
NFLX icon
242
Netflix
NFLX
$309B
$375K 0.03%
10,220
– –
SPLV icon
243
Invesco S&P 500 Low Volatility ETF
SPLV
$7.18B
$375K 0.03%
6,809
– –
FBIN icon
244
Fortune Brands Innovations
FBIN
$5.83B
$373K 0.03%
7,639
+468
+7% +$20.8K
HSY icon
245
Hershey
HSY
$37B
$368K 0.03%
2,741
+43
+2% +$5.46K
KLAC icon
246
KLA
KLAC
$272B
$366K 0.03%
30,990
-540
-2% -$6.25K
ESS icon
247
Essex Property Trust
ESS
$18.1B
$354K 0.03%
1,213
-50
-4% -$14.4K
MRSH
248
Marsh
MRSH
$90.1B
$352K 0.03%
3,529
-211
-6% -$20.2K
GWW icon
249
W.W. Grainger
GWW
$61.5B
$346K 0.03%
1,289
– –
WBA
250
DELISTED
Walgreens Boots Alliance
WBA
$337K 0.03%
6,157
-1,985
-24% -$106K
8 9
10
11 12

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.